


Council on Radionuclides and Radiopharmaceuticals, (CORAR) Revenue
Pharmaceutical Manufacturing • Washington, District of Columbia, United States • 1-10 Employees
Council on Radionuclides and Radiopharmaceuticals, (CORAR) revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Council on Radionuclides and Radiopharmaceuticals, (CORAR)
Shahe Bagerdjian
Vice Chairman Board Directors
Company overview
| Headquarters | 500 N CAPITOL ST NW STE 210, WASHINGTON, District of Columbia 20001, US |
| Website | |
| NAICS | 3254 |
| SIC | 861 |
| Employees | 1-10 |
| Socials |
About Council on Radionuclides and Radiopharmaceuticals, (CORAR)
The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) is the trade association and voice of the radionuclide and radiopharmaceutical industry in North America. People around the world each year benefit from the longstanding commitment CORAR’s members make to research and development, manufacturing and distribution of radiopharmaceuticals and radionuclides—which are used as tracers in the diagnosis and treatment of many diseases. To find out more about CORAR, please visit corar.org/about
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Council on Radionuclides and Radiopharmaceuticals, (CORAR) has never raised funding before.
Council on Radionuclides and Radiopharmaceuticals, (CORAR) Tech Stack
Discover the technologies and tools that power Council on Radionuclides and Radiopharmaceuticals, (CORAR)'s digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
JavaScript libraries
Security
Ecommerce
Performance
Tag managers
Miscellaneous
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
Frequently asked questions
4.8
40,000 users



